Free Trial
→ Musk’s Project Colossus could mint millionaires (From Brownstone Research) (Ad) Buy NNOX Stock  Free NNOX Stock Alerts

Nano-X Imaging (NNOX) Financials

Nano-X Imaging logo
$5.49 +0.01 (+0.18%)
Closing price 05/20/2025 04:00 PM Eastern
Extended Trading
$5.57 +0.08 (+1.49%)
As of 09:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Nano-X Imaging

Annual Income Statements for Nano-X Imaging

This table shows Nano-X Imaging's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Net Income / (Loss) Attributable to Common Shareholders		 -54 -61 -113 -62 -44 -23 -1.91
Consolidated Net Income / (Loss)		 -54 -61 -113 -62 -44 -23 -1.91
Net Income / (Loss) Continuing Operations		 -54 -61 -113 -62 -44 -23 -1.90
Total Pre-Tax Income 		-54 -61 -117 -62 -44 -23 -1.90
Total Operating Income		 -57 -63 -118 -62 -44 -23 -1.90
Total Gross Profit		 -11 -6.59 -6.88 -1.51 0.00 0.00 0.00
Total Revenue		 11 9.91 8.58 1.30 0.00 0.00 0.00
Operating Revenue		 11 9.91 8.58 1.30 0.00 0.00 -
Total Cost of Revenue		 22 16 15 2.82 0.00 0.00 0.00
Operating Cost of Revenue		 22 16 15 2.82 0.00 0.00 -
Total Operating Expenses		 46 60 131 60 44 23 1.90
Selling, General & Admin Expense		 22 24 41 35 22 18 1.02
Marketing Expense		 3.41 4.17 4.38 7.03 12 1.56 0.21
Research & Development Expense		 20 26 27 17 9.21 2.72 0.67
Other Operating Expenses / (Income)		 0.09 -1.42 8.19 1.18 - - -
Impairment Charge		 0.00 7.42 51 0.00 0.00 - -
Total Other Income / (Expense), net		 3.18 5.80 21 -0.61 0.11 0.01 0.00
Interest & Investment Income		 2.87 -0.18 0.79 0.00 0.11 0.01 -
Other Income / (Expense), net		 0.31 5.98 20 -0.61 0.00 0.00 -
Income Tax Expense		 -0.36 -0.34 -3.68 -0.05 0.00 0.00 -
Basic Earnings per Share		 ($0.91) ($1.08) ($2.17) ($1.28) ($1.23) ($0.90) ($0.09)
Weighted Average Basic Shares Outstanding		 58.67M 56.37M 52.24M 48.22M 35.65M 25.18M 20.79M
Weighted Average Diluted Shares Outstanding		 58.67M 57.78M 55.09M 51.79M 35.65K 25.18M 20.79M
Weighted Average Basic & Diluted Shares Outstanding		 58.67M 57.78M 55.09M 51.79M 35.65K 25.18M 20.79M

Quarterly Income Statements for Nano-X Imaging

No quarterly income statements for Nano-X Imaging are available.

Annual Cash Flow Statements for Nano-X Imaging

This table details how cash moves in and out of Nano-X Imaging's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Net Change in Cash & Equivalents		 -17 18 -28 -147 206 8.21 -0.06
Net Cash From Operating Activities		 -37 -45 -43 -38 -22 -5.52 -3.67
Net Cash From Continuing Operating Activities		 -37 -45 -43 -38 -22 -5.52 -3.67
Net Income / (Loss) Continuing Operations		 -54 -61 -113 -62 -44 -23 -1.91
Consolidated Net Income / (Loss)		 -54 -61 -113 -62 -44 -23 -1.91
Depreciation Expense		 1.12 1.20 0.91 0.52 0.21 0.05 0.04
Amortization Expense		 10 11 12 1.55 0.00 0.00 -
Non-Cash Adjustments To Reconcile Net Income		 6.95 16 70 19 25 16 0.12
Changes in Operating Assets and Liabilities, net		 -1.50 -12 -13 2.63 -2.66 0.74 -1.91
Net Cash From Investing Activities		 -20 35 15 -116 -14 -0.13 -0.07
Net Cash From Continuing Investing Activities		 -20 35 15 -116 -14 -0.13 -0.07
Purchase of Property, Plant & Equipment		 -2.77 -3.30 -7.17 -23 -14 -0.13 -0.07
Acquisitions		 0.00 0.00 -1.01 -2.86 0.00 0.00 -
Purchase of Investments		 -59 0.00 -8.45 -104 0.00 0.00 -
Sale and/or Maturity of Investments		 41 39 31 14 0.00 - -
Other Investing Activities, net		 0.05 -0.37 0.00 0.00 - - -
Net Cash From Financing Activities		 40 27 0.80 7.38 241 14 3.68
Net Cash From Continuing Financing Activities		 40 27 0.80 7.38 241 14 3.68
Repayment of Debt		 0.00 0.00 -0.15 0.00 0.00 -0.34 0.00
Issuance of Common Equity		 38 27 0.00 0.00 240 14 3.68
Other Financing Activities, net		 1.67 0.11 0.95 3.58 0.63 0.16 0.00
Cash Interest Paid		 0.14 0.15 0.09 0.01 0.00 - -
Cash Income Taxes Paid		 0.05 0.00 0.15 0.01 0.01 - -

Quarterly Cash Flow Statements for Nano-X Imaging

No quarterly cash flow statements for Nano-X Imaging are available.

Annual Balance Sheets for Nano-X Imaging

This table presents Nano-X Imaging's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Total Assets		 210 219 254 363 236 12
Total Current Assets		 79 89 82 95 220 9.64
Cash & Equivalents		 39 56 38 67 213 8.07
Restricted Cash		 0.00 0.05 0.00 - - -
Short-Term Investments		 18 26 39 22 0.00 -
Accounts Receivable		 1.81 1.48 0.98 1.05 0.00 -
Inventories, net		 1.49 2.36 0.00 - - -
Prepaid Expenses		 0.83 1.27 2.41 3.13 4.79 1.56
Other Current Assets		 17 1.09 1.45 1.97 1.54 -
Plant, Property, & Equipment, net		 45 42 44 37 14 0.23
Total Noncurrent Assets		 86 88 128 231 2.34 2.01
Intangible Assets		 70 81 91 102 0.00 -
Other Noncurrent Operating Assets		 16 7.06 4.09 2.91 2.34 2.01
Total Liabilities & Shareholders' Equity		 210 219 254 363 236 12
Total Liabilities		 21 23 37 71 5.40 21
Total Current Liabilities		 14 16 25 53 4.48 20
Short-Term Debt		 3.06 3.49 4.25 0.15 0.00 0.14
Accounts Payable		 2.21 3.30 3.62 3.13 0.44 0.55
Accrued Expenses		 3.97 3.92 12 3.61 1.93 1.83
Current Deferred Revenue		 0.14 0.54 0.18 0.25 0.00 -
Other Current Liabilities		 4.59 4.27 4.78 46 2.11 18
Total Noncurrent Liabilities		 6.91 7.61 12 18 0.92 0.39
Noncurrent Deferred & Payable Income Tax Liabilities		 2.58 2.95 3.33 7.06 0.00 -
Other Noncurrent Operating Liabilities		 4.34 4.66 4.97 7.00 0.92 0.39
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 189 196 217 292 231 -8.78
Total Preferred & Common Equity		 189 196 217 292 231 -8.78
Total Common Equity		 189 196 217 292 231 -8.78
Common Stock		 563 516 478 439 315 32
Retained Earnings		 -374 -320 -259 -146 -84 -41
Accumulated Other Comprehensive Income / (Loss)		 -0.00 -0.31 -1.97 -0.61 0.00 -

Quarterly Balance Sheets for Nano-X Imaging

No quarterly balance sheets for Nano-X Imaging are available.

Annual Metrics And Ratios for Nano-X Imaging

This table displays calculated financial ratios and metrics derived from Nano-X Imaging's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Growth Metrics		 - - - - - - -
Revenue Growth		 13.91% 15.47% 557.82% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 1.29% 47.81% -40.50% -37.46% -94.13% -1,104.82% 0.00%
EBIT Growth		 2.86% 41.84% -56.57% -41.53% -94.60% -1,085.45% 0.00%
NOPAT Growth		 9.34% 46.83% -91.22% -40.15% -94.60% -1,085.45% 0.00%
Net Income Growth		 11.95% 46.33% -83.25% -41.04% -94.19% -1,081.93% 0.00%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 18.27% -3.21% -13.99% -76.13% -291.18% -50.48% 0.00%
Free Cash Flow Firm Growth		 -48.51% 39.80% 61.02% -155.42% -7,211.29% 0.00% 0.00%
Invested Capital Growth		 15.35% -4.12% -12.86% 707.58% 203.40% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - -
Gross Margin		 -94.03% -66.55% -80.21% -115.95% 0.00% 0.00% 0.00%
EBITDA Margin		 -398.54% -444.88% -984.19% -4,608.05% 0.00% 0.00% 0.00%
Operating Margin		 -502.93% -631.89% -1,372.23% -4,720.71% 0.00% 0.00% 0.00%
EBIT Margin		 -500.22% -571.53% -1,134.69% -4,767.25% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 -474.31% -613.59% -1,320.16% -4,739.11% 0.00% 0.00% 0.00%
Tax Burden Percent		 99.34% 99.45% 96.85% 99.92% 100.00% 100.00% 100.26%
Interest Burden Percent		 95.45% 107.96% 120.12% 99.49% 99.75% 99.96% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -31.65% -36.79% -63.11% -54.96% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -10.99% -17.30% -38.20% -44.74% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 3.82% 7.30% 18.60% 31.32% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -27.83% -29.49% -44.51% -23.64% -39.48% 257.04% 0.00%
Cash Return on Invested Capital (CROIC)		 -45.90% -32.58% -49.37% -210.89% -374.66% 0.00% 0.00%
Operating Return on Assets (OROA)		 -26.33% -23.96% -31.55% -20.75% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 -24.97% -25.72% -36.70% -20.62% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -27.83% -29.49% -44.51% -23.64% -39.48% 257.04% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -28.30% -31.09% -52.26% -21.15% -18.99% 257.04% 0.00%
Net Operating Profit after Tax (NOPAT)		 -40 -44 -82 -43 -31 -16 -1.33
NOPAT Margin		 -352.05% -442.33% -960.56% -3,304.49% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -20.65% -19.50% -24.91% -10.22% -11.81% -170.53% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 -20.67% - - - - - -
Cost of Revenue to Revenue		 194.03% 166.55% 180.21% 215.95% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 199.02% 245.05% 480.93% 2,661.73% 0.00% 0.00% 0.00%
R&D to Revenue		 178.87% 262.99% 309.01% 1,313.04% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 408.91% 610.65% 1,529.56% 4,604.75% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -56 -57 -97 -62 -44 -23 -1.90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -45 -44 -84 -60 -44 -23 -1.87
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 2.20 1.80 1.76 2.29 1.82 0.00 0.00
Price to Tangible Book Value (P/TBV)		 3.49 3.05 3.24 5.08 1.82 0.00 0.00
Price to Revenue (P/Rev)		 36.87 35.43 44.56 514.03 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.69 2.33 2.36 3.71 11.90 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 32.03 27.46 33.47 397.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 172.78 0.00
Leverage & Solvency		 - - - - - - -
Debt to Equity		 0.02 0.02 0.04 0.01 0.00 -0.02 0.00
Long-Term Debt to Equity		 0.00 0.00 0.02 0.01 0.00 0.00 0.00
Financial Leverage		 -0.35 -0.42 -0.49 -0.70 -1.00 0.90 0.00
Leverage Ratio		 1.11 1.15 1.21 1.15 1.12 -1.35 0.00
Compound Leverage Factor		 1.06 1.24 1.46 1.14 1.11 -1.35 0.00
Debt to Total Capital		 1.59% 1.75% 3.45% 1.33% 0.00% -1.62% 0.00%
Short-Term Debt to Total Capital		 1.59% 1.75% 1.89% 0.05% 0.00% -1.62% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 1.55% 1.28% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 98.41% 98.25% 96.56% 98.67% 100.00% 101.62% 0.00%
Debt to EBITDA		 -0.07 -0.08 -0.09 -0.07 0.00 -0.01 0.00
Net Debt to EBITDA		 1.22 1.79 1.13 2.54 0.00 0.35 0.00
Long-Term Debt to EBITDA		 0.00 0.00 -0.04 -0.06 0.00 0.00 0.00
Debt to NOPAT		 -0.08 -0.08 -0.09 -0.09 0.00 -0.01 0.00
Net Debt to NOPAT		 1.38 1.80 1.15 3.54 0.00 0.50 0.00
Long-Term Debt to NOPAT		 0.00 0.00 -0.04 -0.09 0.00 0.00 0.00
Altman Z-Score		 9.00 6.64 3.77 4.68 46.52 -7.34 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - -
Current Ratio		 5.63 5.71 3.29 1.80 49.06 0.48 0.00
Quick Ratio		 4.26 5.40 3.13 1.70 47.65 0.40 0.00
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 -58 -39 -64 -165 -65 0.91 0.00
Operating Cash Flow to CapEx		 -1,322.66% -1,355.65% -605.01% -164.35% -155.05% -4,419.20% -5,028.77%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - -
Asset Turnover		 0.05 0.04 0.03 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 6.86 8.05 8.46 0.00 0.00 0.00 0.00
Inventory Turnover		 11.38 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.26 0.23 0.21 0.05 0.00 0.00 0.00
Accounts Payable Turnover		 7.94 4.77 4.58 1.58 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 53.20 45.34 43.15 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 32.09 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 45.95 76.58 79.73 231.30 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 39.34 -31.23 -36.58 -231.30 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 134 117 122 140 17 -17 0.00
Invested Capital Turnover		 0.09 0.08 0.07 0.02 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 18 -5.01 -18 122 34 -17 0.00
Enterprise Value (EV)		 361 272 287 518 206 157 0.00
Market Capitalization		 416 351 382 670 419 165 165
Book Value per Share		 $3.27 $3.55 $4.18 $6.34 $6.47 ($0.35) $0.00
Tangible Book Value per Share		 $2.06 $2.09 $2.28 $2.86 $6.47 ($0.35) $0.00
Total Capital		 192 199 224 296 231 -8.64 0.00
Total Debt		 3.06 3.49 7.73 3.94 0.00 0.14 0.00
Total Long-Term Debt		 0.00 0.00 3.48 3.80 0.00 0.00 0.00
Net Debt		 -55 -79 -95 -153 -213 -7.93 0.00
Capital Expenditures (CapEx)		 2.77 3.30 7.17 23 14 0.13 0.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 10 -5.83 -16 -46 1.85 -19 0.00
Debt-free Net Working Capital (DFNWC)		 68 77 62 42 215 -10 0.00
Net Working Capital (NWC)		 65 73 57 42 215 -11 0.00
Net Nonoperating Expense (NNE)		 14 17 31 19 13 6.76 0.58
Net Nonoperating Obligations (NNO)		 -55 -79 -95 -153 -213 -7.93 0.00
Total Depreciation and Amortization (D&A)		 11 13 13 2.08 0.21 0.05 0.04
Debt-free, Cash-free Net Working Capital to Revenue		 89.19% -58.84% -186.37% -3,562.88% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 600.63% 773.36% 718.55% 3,240.11% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 573.50% 738.12% 669.00% 3,228.99% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 ($0.91) ($1.08) ($2.17) ($1.28) ($1.23) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 58.67M 56.37M 52.24M 48.22M 46.10M 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($1.23) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 58.67M 57.78M 55.09M 51.79M 46.10M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($1.23) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 58.67M 57.78M 55.09M 51.79M 35.65M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -40 -39 -47 -43 -31 -16 -1.33
Normalized NOPAT Margin		 -352.05% -389.89% -545.38% -3,304.49% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 -477.48% -617.01% -1,363.03% -4,742.79% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Nano-X Imaging

No quarterly metrics and ratios for Nano-X Imaging are available.

Frequently Asked Questions About Nano-X Imaging's Financials

When does Nano-X Imaging's fiscal year end?

According to the most recent income statement we have on file, Nano-X Imaging's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Nano-X Imaging's net income changed over the last 6 years?

Nano-X Imaging's net income appears to be on an upward trend, with a most recent value of -$53.52 million in 2024, rising from -$1.91 million in 2018. The previous period was -$60.78 million in 2023. View Nano-X Imaging's forecast to see where analysts expect Nano-X Imaging to go next.

What is Nano-X Imaging's operating income?
Nano-X Imaging's total operating income in 2024 was -$56.75 million, based on the following breakdown:
  • Total Gross Profit: -$10.61 million
  • Total Operating Expenses: $46.14 million
How has Nano-X Imaging revenue changed over the last 6 years?

Over the last 6 years, Nano-X Imaging's total revenue changed from $0.00 in 2018 to $11.28 million in 2024, a change of 1,128,300,000.0%.

How much debt does Nano-X Imaging have?

Nano-X Imaging's total liabilities were at $20.88 million at the end of 2024, a 9.7% decrease from 2023, and a 1.1% increase since 2019.

How much cash does Nano-X Imaging have?

In the past 5 years, Nano-X Imaging's cash and equivalents has ranged from $8.07 million in 2019 to $213.47 million in 2020, and is currently $39.30 million as of their latest financial filing in 2024.

How has Nano-X Imaging's book value per share changed over the last 6 years?

Over the last 6 years, Nano-X Imaging's book value per share changed from 0.00 in 2018 to 3.27 in 2024, a change of 327.3%.


Related Companies

This page (NASDAQ:NNOX) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored